HELM INTELLIGENCEHIMS
Preparing your analysis.
We’re bringing the available data and research into view. Your report will appear here when it’s ready.
Working on your request
We’re bringing the available data and research into view. Your report will appear here when it’s ready.
Investors may consider the mixed indicators of growth and profitability when evaluating Hims & Hers Health, Inc.
Hims & Hers Health, Inc. has a market capitalization of approximately $7.11B and a current stock price of $27.52, reflecting a day range between $26.74 and $27.62. The company's P/E ratio is 53.95, while its P/S ratio stands at 3.03, and it has exhibited a revenue growth of 59.00% year-over-year, though its EPS growth is down by 3.77%. The stock's 52-week range is between $13.75 and $65.28.
Some investors cite the impressive revenue growth of 59.00% year-over-year as a positive indicator of Hims & Hers' expanding market presence. Additionally, the company's return on equity (ROE) of 23.73% suggests efficient management and potential for profitability.
Conversely, concerns arise with the negative EPS growth of 3.77%, indicating potential challenges in profitability despite revenue growth. Furthermore, the high P/E ratio of 53.95 may suggest that the stock is priced for perfection, which could pose risks if future growth does not meet expectations.
Want AI analysis of your entire portfolio?
Helm Terminal connects to your brokerage, analyzes every holding, and delivers actionable intelligence weekly. Free to start.
Get started freeHelm provides financial data for informational purposes only. This is not financial, investment, or tax advice. Consult a qualified professional before making financial decisions.
Watch my tickers
Get an email when something changes on your tickers: the exact quote, dated and sourced. No account, no brokerage connection, unsubscribe anytime.
Hims & Hers Health, Inc. has a market capitalization of approximately $7.11B and a current stock price of $27.52, reflecting a day range between $26.74 and $27.62. The company's P/E ratio is 53.95, while its P/S ratio stands at 3.03, and it has exhibited a revenue growth of 59.00% year-over-year, though its EPS growth is down by 3.77%. The stock's 52-week range is between $13.75 and $65.28.
Conversely, concerns arise with the negative EPS growth of 3.77%, indicating potential challenges in profitability despite revenue growth. Furthermore, the high P/E ratio of 53.95 may suggest that the stock is priced for perfection, which could pose risks if future growth does not meet expectations.
Some investors cite the impressive revenue growth of 59.00% year-over-year as a positive indicator of Hims & Hers' expanding market presence. Additionally, the company's return on equity (ROE) of 23.73% suggests efficient management and potential for profitability.
Some investors cite the impressive revenue growth of 59.00% year-over-year as a positive indicator of Hims & Hers' expanding market presence. Additionally, the company's return on equity (ROE) of 23.73% suggests efficient management and potential for profitability. Conversely, concerns arise with the negative EPS growth of 3.77%, indicating potential challenges in profitability despite revenue growth. Furthermore, the high P/E ratio of 53.95 may suggest that the stock is priced for perfection, which could pose risks if future growth does not meet expectations.
Hims & Hers Health, Inc. has a market capitalization of approximately $7.11B and a current stock price of $27.52, reflecting a day range between $26.74 and $27.62. The company's P/E ratio is 53.95, while its P/S ratio stands at 3.03, and it has exhibited a revenue growth of 59.00% year-over-year, though its EPS growth is down by 3.77%. The stock's 52-week range is between $13.75 and $65.28.
Helm's analysis is generated by an AI model from live market data. It identifies risk signals, opportunities, and key metrics based on current fundamentals, recent price action, and analyst consensus. It does not execute trades, issue certified investment advice, or predict future prices.
Not financial advice. Informational use only. AI-generated content may contain errors. Consult a licensed financial advisor before making investment decisions. Helm Terminal is not registered as an investment advisor.
Helm Terminal offers free AI-powered stock analysis for HIMS at helmterminal.dev/analyze/HIMS, updated continuously during US market hours. No signup required.